Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Amy Franks

Concepts (190)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Education, Pharmacy
18
2024
144
8.490
Why?
Schools, Pharmacy
8
2024
52
3.630
Why?
Pharmacy
3
2023
54
2.100
Why?
Writing
4
2024
44
1.790
Why?
Students, Pharmacy
5
2024
122
1.720
Why?
Faculty
7
2024
72
1.280
Why?
Professional-Patient Relations
3
2019
46
1.270
Why?
Teaching
4
2024
113
1.100
Why?
Educational Measurement
6
2019
204
1.010
Why?
Career Choice
1
2024
110
0.870
Why?
Students
3
2024
220
0.860
Why?
Pharmaceutical Services
2
2023
52
0.860
Why?
Learning
2
2024
158
0.820
Why?
Fellowships and Scholarships
2
2020
118
0.810
Why?
Humans
43
2024
49877
0.800
Why?
Pharmacies
1
2023
60
0.790
Why?
Biomedical Research
1
2024
241
0.760
Why?
Patient-Centered Care
2
2019
129
0.690
Why?
Motivational Interviewing
2
2019
32
0.680
Why?
Health Knowledge, Attitudes, Practice
4
2018
488
0.660
Why?
Program Development
2
2018
162
0.590
Why?
Blood Pressure
3
2012
520
0.590
Why?
Probucol
2
2009
3
0.590
Why?
Mass Screening
2
2011
346
0.570
Why?
Achievement
1
2017
39
0.570
Why?
Patient Education as Topic
2
2011
314
0.570
Why?
Perception
1
2017
114
0.540
Why?
Cross-Sectional Studies
7
2020
1573
0.520
Why?
Feedback
1
2016
52
0.520
Why?
Tetrazoles
2
2008
40
0.510
Why?
Antihypertensive Agents
2
2009
124
0.500
Why?
Hypertension
3
2009
532
0.480
Why?
Health Personnel
1
2017
250
0.470
Why?
Research Personnel
2
2024
65
0.430
Why?
Curriculum
5
2019
397
0.410
Why?
Community Health Services
2
2011
101
0.400
Why?
Energy Drinks
1
2012
6
0.400
Why?
Female
17
2024
26555
0.400
Why?
Caffeine
1
2012
64
0.380
Why?
Platelet Aggregation Inhibitors
2
2012
174
0.380
Why?
Faculty, Medical
2
2023
92
0.370
Why?
Coronary Disease
1
2011
152
0.360
Why?
Universities
2
2024
169
0.350
Why?
Cardiovascular Diseases
3
2012
447
0.350
Why?
Male
15
2024
25427
0.350
Why?
Adrenergic beta-Antagonists
1
2009
106
0.320
Why?
Cardiovascular System
1
2009
50
0.320
Why?
Biphenyl Compounds
1
2008
31
0.310
Why?
Angiotensin II Type 1 Receptor Blockers
1
2008
43
0.300
Why?
Benzimidazoles
1
2008
49
0.300
Why?
Thiazolidinediones
1
2007
82
0.270
Why?
Adult
11
2024
13344
0.270
Why?
Coronary Restenosis
1
2005
31
0.260
Why?
Hypoglycemic Agents
1
2007
169
0.250
Why?
Clinical Trials as Topic
4
2009
466
0.230
Why?
Program Evaluation
2
2024
347
0.230
Why?
Smoking
2
2018
506
0.230
Why?
Policy
1
2023
24
0.220
Why?
Career Mobility
1
2023
28
0.220
Why?
Organizational Policy
1
2023
38
0.220
Why?
Academies and Institutes
1
2023
18
0.220
Why?
Communication
2
2022
246
0.210
Why?
Checklist
1
2023
29
0.210
Why?
Angiotensin Receptor Antagonists
1
2003
19
0.210
Why?
Imidazoles
1
2003
128
0.200
Why?
Schools
1
2023
162
0.200
Why?
Angiotensin II
1
2003
162
0.190
Why?
Heart Failure
1
2007
505
0.190
Why?
Itraconazole
3
2008
41
0.180
Why?
Diabetes Mellitus, Type 2
1
2007
484
0.180
Why?
Amiodarone
1
2000
22
0.180
Why?
Qualitative Research
1
2023
337
0.180
Why?
Cannabis
1
2023
140
0.180
Why?
Anti-Arrhythmia Agents
1
2000
81
0.180
Why?
Blood Pressure Monitoring, Ambulatory
2
2012
36
0.180
Why?
Mentors
1
2020
55
0.180
Why?
Heart Arrest
2
2007
150
0.170
Why?
Self Report
1
2020
202
0.160
Why?
Peer Review
1
2018
9
0.160
Why?
Self-Assessment
2
2016
44
0.150
Why?
Pilot Projects
3
2009
702
0.150
Why?
Publishing
1
2018
38
0.150
Why?
Motivation
1
2020
273
0.150
Why?
Risk Factors
4
2011
3608
0.150
Why?
Knowledge
1
2017
28
0.140
Why?
Citrus paradisi
2
2008
10
0.130
Why?
Food-Drug Interactions
2
2008
14
0.130
Why?
Education, Pharmacy, Graduate
1
2016
19
0.130
Why?
Tobacco Products
1
2018
125
0.130
Why?
Pharmacists
3
2023
143
0.120
Why?
Arkansas
3
2023
1987
0.120
Why?
Middle Aged
7
2023
12289
0.110
Why?
Young Adult
3
2018
4027
0.110
Why?
Retrospective Studies
2
2024
6118
0.110
Why?
Antifungal Agents
2
2008
343
0.110
Why?
United States
2
2021
4873
0.100
Why?
Dose-Response Relationship, Drug
2
2008
1354
0.100
Why?
Ticlopidine
1
2012
55
0.100
Why?
Proton Pump Inhibitors
1
2012
84
0.100
Why?
Life Style
1
2011
140
0.090
Why?
Drug Interactions
3
2012
207
0.090
Why?
Atenolol
1
2009
14
0.090
Why?
Health Behavior
1
2011
249
0.080
Why?
Cerebrovascular Disorders
1
2009
48
0.080
Why?
Drug Tolerance
1
2009
59
0.080
Why?
Drug Evaluation, Preclinical
1
2009
145
0.080
Why?
Beverages
2
2008
56
0.070
Why?
Problem-Based Learning
1
2008
47
0.070
Why?
Education, Medical, Undergraduate
1
2008
83
0.070
Why?
Hirudins
1
2007
16
0.070
Why?
Anaphylaxis
1
2007
70
0.070
Why?
Edema
1
2007
68
0.070
Why?
Drugs, Investigational
1
2005
14
0.060
Why?
Students, Medical
1
2008
159
0.060
Why?
Weight Gain
1
2007
231
0.060
Why?
Insulin Resistance
1
2007
255
0.060
Why?
Molecular Structure
1
2005
293
0.060
Why?
Insulin
1
2007
453
0.060
Why?
Risk Assessment
1
2009
1253
0.060
Why?
Anticoagulants
1
2007
253
0.060
Why?
beta-Cyclodextrins
1
2004
16
0.060
Why?
Tachycardia, Ventricular
2
2003
43
0.060
Why?
Antioxidants
1
2005
234
0.060
Why?
Ephedra
1
2003
8
0.050
Why?
Electrocardiography, Ambulatory
1
2003
23
0.050
Why?
Phytotherapy
1
2003
42
0.050
Why?
Plant Preparations
1
2003
39
0.050
Why?
Receptors, Angiotensin
1
2003
13
0.050
Why?
Prescription Fees
1
2003
14
0.050
Why?
Hemostasis
1
2003
56
0.050
Why?
Adolescent
2
2018
6402
0.050
Why?
Practice Guidelines as Topic
2
2007
456
0.050
Why?
Animals
2
2009
13098
0.050
Why?
Aged, 80 and over
1
2009
3137
0.050
Why?
Hepatocytes
1
2003
179
0.050
Why?
Interleukin-6
1
2003
265
0.050
Why?
Ventricular Fibrillation
1
2000
16
0.050
Why?
Attitude of Health Personnel
1
2023
346
0.040
Why?
Aged
2
2012
9450
0.040
Why?
Dietary Supplements
1
2003
437
0.040
Why?
Attitude
1
2019
69
0.040
Why?
Cardiopulmonary Resuscitation
1
2000
138
0.040
Why?
Liver
1
2003
1105
0.040
Why?
Risk
1
2018
314
0.040
Why?
Pregnant Women
1
2018
74
0.040
Why?
Nicotine
1
2018
182
0.030
Why?
Attitude to Health
1
2018
190
0.030
Why?
Societies, Pharmaceutical
1
2016
12
0.030
Why?
Pandemics
1
2021
567
0.030
Why?
Pharmaceutical Solutions
2
2008
8
0.030
Why?
Child
1
2008
6826
0.030
Why?
Accreditation
1
2016
59
0.030
Why?
Area Under Curve
2
2008
178
0.030
Why?
Cross-Over Studies
2
2008
223
0.030
Why?
Time Factors
2
2012
2890
0.020
Why?
Regression Analysis
1
2012
385
0.020
Why?
Acute Coronary Syndrome
1
2012
78
0.020
Why?
Proportional Hazards Models
1
2012
406
0.020
Why?
Pregnancy
1
2018
2466
0.020
Why?
Cohort Studies
1
2012
1406
0.020
Why?
Peer Group
1
2008
54
0.020
Why?
Hospitalization
1
2012
663
0.020
Why?
Cytochrome P-450 CYP3A
1
2008
77
0.020
Why?
Risk Management
1
2007
32
0.020
Why?
Injections, Intravenous
1
2007
135
0.020
Why?
Follow-Up Studies
1
2012
2176
0.020
Why?
Antibodies
1
2007
151
0.020
Why?
Administration, Oral
1
2008
430
0.020
Why?
Renal Insufficiency
1
2007
107
0.020
Why?
Respiratory Insufficiency
1
2007
115
0.020
Why?
Recombinant Proteins
1
2007
482
0.020
Why?
Sex Factors
1
2008
691
0.020
Why?
Clinical Competence
1
2008
395
0.020
Why?
Cyclodextrins
1
2004
18
0.010
Why?
Biological Availability
1
2004
99
0.010
Why?
Ephedrine
1
2003
21
0.010
Why?
Cimetidine
1
2003
7
0.010
Why?
Receptors, Interleukin-6
1
2003
22
0.010
Why?
Diastole
1
2003
70
0.010
Why?
Bradycardia
1
2003
36
0.010
Why?
Systole
1
2003
71
0.010
Why?
Reference Values
1
2003
302
0.010
Why?
Cytochrome P-450 Enzyme System
1
2003
194
0.010
Why?
Heart Rate
1
2003
299
0.010
Why?
Patient Compliance
1
2003
230
0.010
Why?
Body Weight
1
2003
512
0.010
Why?
Enzyme Inhibitors
1
2003
378
0.010
Why?
Body Mass Index
1
2003
648
0.010
Why?
Cells, Cultured
1
2003
1587
0.010
Why?
Treatment Outcome
1
2003
5174
0.010
Why?
Franks's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description